GLUE · Monte Rosa Therapeutics, Inc.
AI read · Good for GLUE
The AI's read
The findings strengthen the case for testing MRT-8102 in more people. The study also found no serious side effects, and side-effect rates were close to placebo. Still, dosing lasted 4 weeks, and the company says it must finish long-term safety tests before its planned 6-month heart study. The trial measured signs of disease, not heart attacks.